Heart, Kidneys & Metabolism – Revolutionizing outcomes with SGLT2I & SGLT2i+DPP4i combinations

Heart, Kidneys & Metabolism – Revolutionizing outcomes with SGLT2I & SGLT2i+DPP4i combinations

Monday, August 31st 2026 - 2:30 PM (IST)

358 doctors attending

Monday, August 31st 2026 - 2:30 PM (IST)

Medflix

About this session

This session explores the evolving paradigm of cardio-renal-metabolic care, highlighting how SGLT2 inhibitor and DPP-4 inhibitor combinations can improve outcomes in patients with type 2 diabetes and associated co-morbidities. It focuses on mechanisms, patient selection, real-world evidence, and practical strategies to achieve comprehensive heart, kidney, and metabolic protection in routine clinical practice.

Other details

Registration

Free

Duration

60 min

Replay

Yes

Certificate

No

Language

English

Supported by

Supported By

Explore other sessions

Neurological Emergencies: The First 10 Minutes That Matter

Neurological Emergencies: The First 10 Minutes That Matter

31 August 2026 | 3:00 PM (IST)